Pramodini Medicare (NSE:PRAMODINI) EBIT: ₹64.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:PRAMODINI Pramodini Medicare Ltd NSE:PRAMODINI
19 GF Score
Price ₹114.80
! 1 Warning Sign
View Full Analysis

What is Pramodini Medicare EBIT?

Pramodini Medicare NSE:PRAMODINI -2.01% 19 EBIT is ₹64.0 Mil as of Mar. 2026. GuruFocus rates NSE:PRAMODINI with a GF Score™ of 19/100. The stock has 1 warning sign investors should review.

Pramodini Medicare's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹64.0 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹64.0 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Pramodini Medicare's annualized ROC % for the quarter that ended in Mar. 2026 was 26.50%. Pramodini Medicare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 49.24%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Pramodini Medicare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 2.42%.

Pramodini Medicare  (NSE:PRAMODINI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Pramodini Medicare's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=238.36 * ( 1 - 27.78% )/( (631.669 + 667.567)/ 2 )
=172.143592/649.618
=26.50 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=859.857 - 277.993 - ( 47.435 - max(0, 314.677 - 264.872+47.435))
=631.669

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=936.152 - 204.215 - ( 64.37 - max(0, 262.953 - 330.702+64.37))
=667.567

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Pramodini Medicare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=256.132/( ( (506.831 + max(-76.338, 0)) + (489.372 + max(44.226, 0)) )/ 2 )
=256.132/( ( 506.831 + 533.598 )/ 2 )
=256.132/520.2145
=49.24 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(175.386 + 4.541 + 37.51) - (277.993 + 0 + 15.782)
=-76.338

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(174.005 + 9.927 + 82.4) - (204.215 + 0 + 17.891)
=44.226

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Pramodini Medicare's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=64.033/2644.945
=2.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pramodini Medicare EBIT Related Terms

Pramodini Medicare EBIT Historical Data

* Premium members only.

The historical data trend for Pramodini Medicare's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pramodini Medicare EBIT Chart

Pramodini Medicare Annual Data
Trend Mar23 Mar24 Mar25 Mar26
EBIT
96.73 116.94 168.94 244.37

Pramodini Medicare Quarterly Data
Mar23 Mar24 Mar25 Dec25 Mar26
EBIT 0.00 0.00 0.00 0.00 64.03

NSE:PRAMODINI vs HCA, THC, EHC: EBIT Comparison

For the Medical Care Facilities subindustry, Pramodini Medicare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pramodini Medicare EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pramodini Medicare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Pramodini Medicare's EV-to-EBIT falls into.


NSE:PRAMODINI
19GF Score
Pramodini Medicare Ltd NSE:PRAMODINI
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pramodini Medicare EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹64.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹64.0 Mil mean?
Pramodini Medicare (NSE:PRAMODINI) has a EBIT of ₹64.0 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Pramodini Medicare.
Is Pramodini Medicare's EBIT too high?
Pramodini Medicare's current EBIT is ₹64.0 Mil. Overall, Pramodini Medicare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Pramodini Medicare's EBIT compare to HCA and THC?
Pramodini Medicare's EBIT of ₹64.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Pramodini Medicare. Pramodini Medicare's current EBIT is ₹64.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pramodini Medicare stock overvalued right now?
Pramodini Medicare (NSE:PRAMODINI) has a current EBIT of ₹64.0 Mil. The current EBIT is ₹64.0 Mil. Pramodini Medicare's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Pramodini Medicare (NSE:PRAMODINI), the current EBIT is ₹64.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pramodini Medicare Business Description

Address Prakasam Road, D. No: - 29-4-54K, CSI Complex, Suryaraopet, Vijayawada, AP, IND, 520002
Pramodini Medicare Ltd is a diagnostic service provider in India. It provides a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. The company also provide teleradiology services, which functions on a 24*7 basis throughout the year. It provides healthcare services for core testing, patients diagnosis, disease prevention and monitoring of various health conditions. Its services includes both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases.
19GF Score

Get the complete analysis for NSE:PRAMODINI

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹114.80
Price